Since PARP-1 is a key enzyme involved in DNA damage, and inhibition of PARP-1 activation by specific inhibitors prevents the retinal lesions in rodent models of diabetes and I/R injury25, 26, the beneficial effect of minocycline on DNA damage might be due to its ability on inhibition of PARP-1 activation. Here, PARP1 is linked to diabetes mellitus.